Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-23-000334
Filing Date
2023-11-02
Accepted
2023-11-02 13:34:44
Documents
27
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin1030form10q.htm   iXBRL 10-Q 247502
2 EXHIBIT 31.1 skin1030form10qexh31_1.htm EX-31.1 8268
3 EXHIBIT 31.2 skin1030form10qexh31_2.htm EX-31.2 8265
4 EXHIBIT 32.1 skin1030form10qexh32_1.htm EX-32.1 4178
  Complete submission text file 0001554795-23-000334.txt   1110109

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE skin-20230930.xsd EX-101.SCH 8232
6 XBRL CALCULATION FILE skin-20230930_cal.xml EX-101.CAL 15727
7 XBRL DEFINITION FILE skin-20230930_def.xml EX-101.DEF 9602
8 XBRL LABEL FILE skin-20230930_lab.xml EX-101.LAB 90752
9 XBRL PRESENTATION FILE skin-20230930_pre.xml EX-101.PRE 63595
21 EXTRACTED XBRL INSTANCE DOCUMENT skin1030form10q_htm.xml XML 64563
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 231371232
SIC: 6770 Blank Checks